Our Vision: A consortium of Infectious Disease Centers (IDC) to fill treatment gaps and provide additional support.
Our Services at a glance
01The Core Facility (based in Cornell) performs sophisticated sensitivity testing and molecular characterization of samples
02Based on sensitivity and host response data, the Consortium provides access to both approved and clinical stage compounds.
03Our clinical team advises on therapeutic treatment strategies based on lab characterization, and develops protocols for related samples/scenarios based on tracked clinical outcomes.
04When appropriate, our program assists with access to clinical stage compounds through “expanded access” (compassionate use) programs and assists with industry requests, FDA correspondences, eINDs, etc to ease the administrative burden on treating physicians